Nsj Prayog Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 6.00 Cr
as on 02-01-2025
- Paid Up Capital ₹ 5.39 Cr
as on 02-01-2025
- Company Age 6 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.88 Cr
as on 02-01-2025
- Revenue 42.43%
(FY 2021)
- Profit 8.27%
(FY 2021)
- Ebitda 105.38%
(FY 2021)
- Net Worth 40.72%
(FY 2021)
- Total Assets 73.06%
(FY 2021)
About Nsj Prayog Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.00 Cr and a paid-up capital of Rs 5.39 Cr.
The company currently has active open charges totaling ₹7.88 Cr.
Samala Jaya, Krishnaveni Juturu, and Saritha Narayana serve as directors at the Company.
- CIN/LLPIN
U73200TG2018PTC123113
- Company No.
123113
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Mar 2018
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Nsj Prayog Life Sciences Private Limited offer?
Nsj Prayog Life Sciences Private Limited offers a wide range of products and services, including Mosquito & Insect Repellent, Insect Trap.
Who are the key members and board of directors at Nsj Prayog Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samala Jaya  | Director | 19-Mar-2018 | Current |
| Krishnaveni Juturu | Director | 19-Mar-2018 | Current |
| Saritha Narayana | Director | 19-Mar-2018 | Current |
Financial Performance of Nsj Prayog Life Sciences.
Nsj Prayog Life Sciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 42.43% increase. The company also saw a slight improvement in profitability, with a 8.27% increase in profit. The company's net worth Soared by an impressive increase of 40.72%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Nsj Prayog Life Sciences?
In 2021, Nsj Prayog Life Sciences had a promoter holding of 99.98% and a public holding of 0.02%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Karnataka Bank Ltd. Creation Date: 18 Aug 2024 | ₹6.38 Cr | Open |
Karnataka Bank Ltd. Creation Date: 14 Dec 2023 | ₹1.50 Cr | Open |
How Many Employees Work at Nsj Prayog Life Sciences?
Nsj Prayog Life Sciences has a workforce of 32 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Nsj Prayog Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nsj Prayog Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
